Pınar, İ. E. Et Al. 2022. Is split-dose better than single-dose? Results of Turkish Stem Cell Coordination Center (TURKOK) donors in the era of rising biosimilar G-CSF. JOURNAL OF CLINICAL APHERESIS , vol.37, no.5 , 430-437.

Pınar, İ. E., Özkocaman, V., Özkalemkaş, F., Durgut, H., Dakiki, B., Ersal, T., ... Gürsoy, V.(2022). Is split-dose better than single-dose? Results of Turkish Stem Cell Coordination Center (TURKOK) donors in the era of rising biosimilar G-CSF. JOURNAL OF CLINICAL APHERESIS , vol.37, no.5, 430-437.

Pınar, İbrahim Et Al. "Is split-dose better than single-dose? Results of Turkish Stem Cell Coordination Center (TURKOK) donors in the era of rising biosimilar G-CSF," JOURNAL OF CLINICAL APHERESIS , vol.37, no.5, 430-437, 2022

Pınar, İbrahim E. Et Al. "Is split-dose better than single-dose? Results of Turkish Stem Cell Coordination Center (TURKOK) donors in the era of rising biosimilar G-CSF." JOURNAL OF CLINICAL APHERESIS , vol.37, no.5, pp.430-437, 2022

Pınar, İ. E. Et Al. (2022) . "Is split-dose better than single-dose? Results of Turkish Stem Cell Coordination Center (TURKOK) donors in the era of rising biosimilar G-CSF." JOURNAL OF CLINICAL APHERESIS , vol.37, no.5, pp.430-437.

@article{article, author={İbrahim Ethem Pınar Et Al. }, title={Is split-dose better than single-dose? Results of Turkish Stem Cell Coordination Center (TURKOK) donors in the era of rising biosimilar G-CSF}, journal={JOURNAL OF CLINICAL APHERESIS}, year=2022, pages={430-437} }